Jan Braess
Arzt
Geboren:
1968
Hat mitgewirkt an:
-
Pharmakokinetik von YNKO1 (Cytarabine-Ocfosfate) und seiner Metabolite : eine Phase-I-Studie
-
Identifying long-term survivors and those at higher or lower risk of relapse among patients with cytogenetically normal acute myeloid leukemia using a high-dimensional mixture cure model
-
Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia
-
Mediation analysis reveals common mechanisms of RUNX1 point mutations and RUNX1/RUNX1T1 fusions influencing survival of patients with acute myeloid leukemia